Vitamin D levels in patients with and without Chronic Kidney Disease, clinical and epidemiological profile: preliminary analysis in a second level hospital in Quito, Ecuador
Authors
-
André Benítez-Baldassari
Universidad Central del Ecuador, Facultad de Ciencias Médicas, Escuela de Medicina, Quito, Ecuador
https://orcid.org/0000-0002-4898-7102
-
Estefanía León-Hernández
Hospital Pablo Arturo Suárez, Departamento de Nefrología y Unidad de Hemodiálisis, Quito, Ecuador
https://orcid.org/0009-0007-7918-1121
-
Andrea Banegas-Sarmiento
Hospital de Especialidades De las Fuerzas Armadas numero 1 Quito, Servicio de Medicina Interna
https://orcid.org/0000-0001-6993-554X
-
Santiago Aguayo-Moscoso
Hospital Pablo Arturo Suárez, Unidad de Terapia Intensiva, Centro de Investigación Clínica, Quito, Ecuador
https://orcid.org/0000-0003-4919-5497
-
Jorge Luis Vélez-Paéz
Hospital de Especialidades De las Fuerzas Armadas numero 1 Quito, Servicio de Medicina Interna; Universidad Central del Ecuador, Facultad de Ciencias Médicas, Escuela de Medicina, Quito, Ecuador
https://orcid.org/0000-0002-6956-4475
DOI:
https://doi.org/10.70099/BJ/2024.01.01.22Keywords:
vitamin D, enfermedad renal crónica, metabolismAbstract
Vitamin D has been associated with different effects unrelated to bone-mineral metabolism, such as its association with arterial hypertension. This study determines the prevalence profile of vitamin D deficiency and insufficiency in Ecuadorian patients, its epidemiological profile, and its relationship with other diseases such as arterial hypertension, diabetes mellitus, and chronic kidney disease. This is a pioneering study in Ecuador of a retrospective type, carried out at the Pablo Arturo Suarez Hospital over 6 months, in which it was found that the prevalence of vitamin D insufficiency was 28.5% (levels between 21 to 30 ng/ml) and deficiency was 57% (levels less than 20 ng/ml); Likewise, we ratify the inverse relationship between vitamin D levels and age, as well as finding a certain association between vitamin D levels and the presence of arterial hypertension; while no significant differences were found in its relationship with diabetes mellitus, chronic kidney disease without the use of renal replacement therapy and the general population.
References
1. Rochel N. Vitamin D and Its Receptor from a Structural Perspective. Nutrients. 12 de julio de 2022;14(14):2847.
2. Wang H, Chen W, Li D, Yin X, Zhang X, Olsen N, et al. Vitamin D and Chronic Diseases. Aging Dis. 2 de mayo de 2017;8(3):346-53.
3. Bover J, Massó E, Gifre L, Alfieri C, Soler-Majoral J, Fusaro M, et al. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines. Nutrients. 24 de marzo de 2023;15(7):1576.
4. Zhang Y, Darssan D, Pascoe EM, Johnson DW, Pi H, Dong J. Vitamin D status and mortality risk among patients on dialysis: a systematic review and meta-analysis of observational studies. Nephrol Dial Transplant. 1 de octubre de 2018;33(10):1742-51.
5. Martin-Romero A, Perelló-Martínez J, Hidalgo-Santiago JC, Michan-Doña A, Bosco López Sáez J, Gómez-Fernández P. Efecto de la administración de diferentes formas de vitamina D en la presión arterial y rigidez aórticas, y su implicación en la reducción de la albuminuria en la enfermedad renal crónica. Clínica e Investigación en Arteriosclerosis. 1 de noviembre de 2022;34(6):311-21.
6. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, Choukroun G, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. junio de 2009;4(6):1128-35.
7. Jacob AI, Sallman A, Santiz Z, Hollis BW. Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr. julio de 1984;114(7):1313-9.
8. Fournier A, Fardellone P, Achard JM, Ghazali A, Pruna A, El Esper N, et al. Importance of vitamin D repletion in uraemia. Nephrology Dialysis Transplantation. 1 de abril de 1999;14(4):819-23.
9. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D Status and Mortality Risk in CKD: A Meta-analysis of Prospective Studies. American Journal of Kidney Diseases. 1 de septiembre de 2011;58(3):374-82.
10. Coccia P, Blazquez J, Contreras M, Ferraris V, Raddavero C, Ghezzi L, et al. Alta prevalencia de deficiencia de vitamina D en niños con enfermedad renal crónica y trasplante renal. Arch argent pediatr. 2017;220-6.
11. Palacios C, González L. La deficiencia de vitamina D es un problema global de salud pública. Anales Venezolanos de Nutrición. junio de 2014;27(1):57-72.
12. Martínez-Torres J, Barajas-Lizarazo MA, Cárdenas-Malpica PA, Escobar-Velásquez KD, Carvajal-Suárez LS, Moreno-Bayona JA, et al. Prevalencia de la deficiencia e insuficiencia de vitamina D y factores asociados en mujeres colombianas en 2015. Nutrición Hospitalaria. agosto de 2022;39(4):843-51.
13. Herrera-Vázquez A, Avendaño-Vázquez E, Torres-Alarcón CG, Herrera-Vázquez A, Avendaño-Vázquez E, Torres-Alarcón CG. Deficiencia de vitamina D en adultos mayores con fractura de cadera. Medicina interna de México. octubre de 2019;35(5):669-75.
14. Restrepo Valencia CA, Aguirre Arango JV, Restrepo Valencia CA, Aguirre Arango JV. Niveles de vitamina D (25(OH)D) en pacientes con enfermedad renal crónica estadios 2 a 5. Colombia Médica. septiembre de 2016;47(3):160-6.
15. Ureña-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis. octubre de 2011;58(4):544-53.
16. Amrein K, Scherkl M, Hoffmann M, Neuwersch-Sommeregger S, Köstenberger M, Tmava Berisha A, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. noviembre de 2020;74(11):1498-513.
17. López Gavilanez E, Orces CH, Guerrero Franco K, Segale Bajaña A, Veliz Ortega J, Bajaña Granja W, et al. Insuficiencia de vitamina D en mujeres postmenopáusicas ecuatorianas con diabetes mellitus tipo 2. Revista de Osteoporosis y Metabolismo Mineral. marzo de 2018;10(1):7-14.
18. Castellote Varona FJ, Buttazzo M, López Azorín F, Ruiz Espejo F. Niveles de vitamina D en el anciano. Revista española de geriatría y gerontología: Órgano oficial de la Sociedad Española de Geriatría y Gerontología. 2010;45(5 (Septiembre / Octubre)):301-2.
19. Fernández del Buey RM, Castro Barrio M, Martínez Gordillo N, Ruiz Sanz E. Hipovitaminosis D en la población anciana institucionalizada: variables asociadas y valoración geriátrica. Gerokomos. diciembre de 2016;27(4):153-6.
20. Hilger J, Friedel A, Herr R, Rausch T, Roos F, Wahl DA, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr. 14 de enero de 2014;111(1):23-45.
21. Castro Torres Y, Fleites Pérez A, Carmona Puerta R, Vega Valdez M, Santiestebán Castillo I. Déficit de la vitamina D e hipertensión arterial. Evidencias a favor. Revista Colombiana de Cardiología. 1 de enero de 2016;23(1):42-8.
22. Swapna N, Vamsi UM, Usha G, Padma T. Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J Hum Genet. 2011;17(3):201-6.
23. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. julio de 2008;74(2):170-9.
24. Hintzpeter B, Mensink GBM, Thierfelder W, Müller MJ, Scheidt-Nave C. Vitamin D status and health correlates among German adults. Eur J Clin Nutr. septiembre de 2008;62(9):1079-89.
25. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, ethnicity, and blood pressure in the Third National Health and Nutrition Examination Survey. Am J Hypertens. julio de 2007;20(7):713-9.
26. Franca Gois PH, Wolley M, Ranganathan D, Seguro AC. Vitamin D Deficiency in Chronic Kidney Disease: Recent Evidence and Controversies. Int J Environ Res Public Health. 17 de agosto de 2018;15(8):1773.
27. González EA, Sachdeva A, Oliver DA, Martin KJ. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol. 2004;24(5):503-10.
28. Bhan I, Burnett-Bowie SAM, Ye J, Tonelli M, Thadhani R. Clinical Measures Identify Vitamin D Deficiency in Dialysis. Clin J Am Soc Nephrol. marzo de 2010;5(3):460-7.
29. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int. octubre de 2007;72(8):1004-13.
30. Yonemura K, Fujimoto T, Fujigaki Y, Hishida A. Vitamin D deficiency is implicated in reduced serum albumin concentrations in patients with end-stage renal disease. Am J Kidney Dis. agosto de 2000;36(2):337-44.
31. Akimbekov NS, Digel I, Sherelkhan DK, Razzaque MS. Vitamin D and Phosphate Interactions in Health and Disease. Adv Exp Med Biol. 2022;1362:37-46.
32. Cianciolo G, Cappuccilli M, Tondolo F, Gasperoni L, Zappulo F, Barbuto S, et al. Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients. Nutrients. 25 de abril de 2021;13(5):1453.
33. Al-Ishaq RK, Kubatka P, Brozmanova M, Gazdikova K, Caprnda M, Büsselberg D. Health implication of vitamin D on the cardiovascular and the renal system. Archives of Physiology and Biochemistry. 4 de mayo de 2021;127(3):195-209.
34 Christodoulou M, Aspray TJ, Schoenmakers · Inez. Vitamin D Supplementation for Patients with Chronic Kidney Disease: A Systematic Review and Meta-analyses of Trials Investigating the Response to Supplementation and an Overview of Guidelines. 2021 [cited 2023 Dec 16];109:157–78. Available from: https://doi.org/10.1007/s00223-021-00844-1
35 A Clinical Update on Vitamin D Deficiency and Secondary Hyperparathyroidism: Vitamin D Testing and Supplementation in CKD Stages 3-4 Part 2 References. 2016 [cited 2023 Dec 16]; Available from: www.opko.com/products/point-of-care-diagnostics/.
36 Koizumi M, Komaba H, Fukagawa M. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Contrib Nephrol [Internet]. 2013 [cited 2023 Dec 16];180:110–23. Available from: https://pubmed.ncbi.nlm.nih.gov/23652554/
37 Dogan E, Erkoc R, Sayarlioglu H, Soyoral Y, Dulger H. Effect of depot oral cholecalciferol treatment on secondary hyperparathyroidism in stage 3 and stage 4 chronic kidney diseases patients. Ren Fail [Internet]. 2008 May [cited 2023 Dec 16];30(4):407–10. Available from: https://www.tandfonline.com/action/journalInformation?journalCode=irnf20
38 Sprague SM, Crawford PW, Melnick JZ, Strugnell SA, Ali S, Mangoo-Karim R, et al. Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease. Am J Nephrol [Internet]. 2016 Oct 18 [cited 2023 Dec 16];44(4):316–25. Available from: https://dx.doi.org/10.1159/000450766
39 Larsen T, Mose FH, Bech JN, Pedersen EB. Effect of paricalcitol on renin and albuminuria in non-diabetic stage III-IV chronic kidney disease: A randomized placebo-controlled trial. BMC Nephrol [Internet]. 2013 Jul 26 [cited 2023 Dec 16];14(1):1–11. Available from: https://bmcnephrol.biomedcentral.com/articles/10.1186/1471-2369-14-163
40 Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, et al. Paricalcitol Reduces Albuminuria and Inflammation in Chronic Kidney Disease. Hypertension [Internet]. 2008 Aug 1 [cited 2023 Dec 16];52(2):249–55. Available from: https://www.ahajournals.org/doi/abs/10.1161/HYPERTENSIONAHA.108.113159
41 Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, et al. Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease: The PRIMO Randomized Controlled Trial. JAMA [Internet]. 2012 Feb 15 [cited 2023 Dec 16];307(7):674–84. Available from: https://jamanetwork.com/journals/jama/fullarticle/1104984
Published
How to Cite
Issue
Section
Categories
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with BioNatura Journal agree to the following terms: Authors retain copyright and grant the BioNatura Institutional Publishing Consortium (BIPC) right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). This allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
